Albert Chiou is a Dermatology physician affiliated with Stanford Medicine. OpenAlex indexes 85 publications with 1,498 citations (h-index 21); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 16 Apr 2024.
Clinical trials
- 12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi
Sponsor: Albert Chiou
- A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa
Sponsor: Stanford University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20241 payment
- PFIZER INC.Program year20232 payments
- PFIZER INC.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
38.7%Azole Antifungal22.6%Ketoconazole100%Part D≥46 patientsNitroimidazole Antimicrobial7.4%Metronidazole100%Part D≥11 patients+ 2 more classes in this area
Sensory organs
19.4%Corticosteroid16.6%Clobetasol Propionate51%Hydrocortisone49%Part D≥31 patientsSulfonamide Antibacterial2.7%Sulfacetamide Sodium100%Part D<11 patientsDermatology
18.6%Corticosteroid13.6%Triamcinolone Acetonide100%Part D≥39 patientsInterleukin-4 Receptor alpha Antagonist5%Dupixent Syringe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MedHELM: Holistic Evaluation of Large Language Models for Medical Tasks
arXiv (Cornell University)
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Ranjana Advani, MD
Stanford Medicine
Michael Weisman, MD
Stanford Medicine
Maurice Ohayon, MD, DSC, PhD
Stanford Medicine
Bruno Medeiros, MD
Stanford Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”